Medicare Enrolled
Dr. Umama Adil, MD
Pulmonary Disease · Quincy, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Adil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Adil?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Adil
Dr. Umama Adil is a pulmonary disease specialist in Quincy, IL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Adil performed 1,054 Medicare services across 808 unique beneficiaries.
Between the years covered by Open Payments, Dr. Adil received a total of $11,838 from 42 pharmaceutical and/or device companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Adil is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 39% volume in IL
$11,838 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,054
Medicare services
Top 39% in IL for pulmonary disease
808
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
197 | $62 | $139 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
162 | $92 | $199 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $72 | $203 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
74 | $135 | $390 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
45 | $10 | $41 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
38 | $31 | $875 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
38 | $6 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $100 | $316 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
34 | $12 | $27 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $109 | $273 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
30 | $8 | $34 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $50 | $137 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $102 | $266 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
26 | $54 | $1,080 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
23 | $74 | $3,489 |
| New patient office visit, complex (60-74 min) | 23 | $129 | $393 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
21 | $122 | $2,622 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
20 | $51 | $310 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
19 | $47 | $102 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
18 | $10 | $126 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
17 | $127 | $1,687 |
| Chest fluid drainage with tube insertion using imaging guidance This procedure removes fluid from the chest cavity and places a tube to stay in place for ongoing drainage. Imaging guidance is used to help position the tube accurately. |
15 | $116 | $495 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
13 | $80 | $171 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
12 | $25 | $63 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
11 | $22 | $53 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,838
Total received (2018-2024)
Avg $1,691/year across 7 years
Top 18% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
278
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,349 (62.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,488 (37.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,209
2023
$5,903
2022
$2,196
2021
$17
2020
$546
2019
$1,201
2018
$766
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$229
Actelion Pharmaceuticals US, Inc.
$176
Boehringer Ingelheim Pharmaceuticals, Inc.
$139
GlaxoSmithKline, LLC.
$133
Insmed, Inc.
$95
Regeneron Healthcare Solutions, Inc.
$86
Electromed, Inc.
$80
Mylan Specialty L.P.
$73
Amgen Inc.
$47
Grifols USA, LLC
$44
GENZYME CORPORATION
$33
JAZZ PHARMACEUTICALS INC.
$22
Mallinckrodt Hospital Products Inc.
$19
HARMONY BIOSCIENCES LLC
$19
ABBVIE INC.
$14
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$4,552
Ethicon Inc.
$1,287
AstraZeneca Pharmaceuticals LP
$849
GlaxoSmithKline, LLC.
$655
Allergan Inc.
$563
Actelion Pharmaceuticals US, Inc.
$533
Boehringer Ingelheim Pharmaceuticals, Inc.
$498
Pulmonx Corporation
$498
Regeneron Healthcare Solutions, Inc.
$239
La Jolla Pharmaceutical Company
$194
Insmed, Inc.
$178
Amgen Inc.
$172
Electromed, Inc.
$159
Mylan Specialty L.P.
$125
Bayer HealthCare Pharmaceuticals Inc.
$122
PFIZER INC.
$119
Merck Sharp & Dohme Corporation
$114
GENZYME CORPORATION
$109
Grifols USA, LLC
$107
United Therapeutics Corporation
$92
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$88
Allergan, Inc.
$71
Alexion Pharmaceuticals, Inc.
$67
Philips Electronics North America Corporation
$49
Resmed Corp
$46
AbbVie Inc.
$43
Paratek Pharmaceuticals, Inc.
$36
Merck Sharp & Dohme LLC
$24
Chiesi USA, Inc.
$23
Relypsa, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$22
Novartis Pharmaceuticals Corporation
$20
Circassia Pharmaceuticals Inc
$20
Mallinckrodt Hospital Products Inc.
$19
HARMONY BIOSCIENCES LLC
$19
Edwards Lifesciences Corporation
$18
Baxter Healthcare
$17
Harmony Biosciences LLC
$16
Itamar Medical Inc
$15
ZOLL Circulation Inc
$15
ABBVIE INC.
$14
BOSTON SCIENTIFIC CORPORATION
$12
Top 3 companies account for 56.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · AVYCAZ · Adempas · Arikayce · BREZTRI · CARDENE · CHARTIS CATHETER · DUPIXENT · Da Vinci Surgical System · ELIQUIS · FASENRA · FloTrac Sensor · GENERAL PULMONARY · GIAPREZA · Hillrom - Life 2000 Ventilation System · ION · LOKELMA · Monarch Platform · NONE · NUCALA · NUZYRA · OFEV · OPSUMIT · Prolastin-C Liquid · RELISTOR · REMODULIN · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Temperature Management System · ULTOMIRIS · UPTRAVI · Ultomiris · Veltassa · WAKIX · WatchPAT · Wellcentive Undiv · XIFAXAN · XOLAIR · XYWAV · YUPELRI · Yupelri · ZEPHYR ENDOBRONCHIAL VALVE · ZERBAXA · myAir
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
4
Per 100K population
6.1
County median income
$64,962
Nearest hospital
BLESSING HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Adil is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of IL peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Adil experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Adil performed 197 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Adil receive payments from pharmaceutical companies?
Yes. Dr. Adil received a total of $11,838 from 42 companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Adil's costs compare to other pulmonary diseases in Quincy?
Dr. Adil's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Adil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Quincy
Browse pulmonary diseases in Quincy ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in IL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in IL
Which IL pulmonary diseases receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Ethicon Inc. Payments to Doctors
See all physicians who received payments from Ethicon Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology